Process View
A series of molecular signals initiated by the binding of interleukin-8 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "interleukin 8 mediated signaling pathway"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CCL5 | chemokine (C-C motif) ligand 5 | 1.000 | ||
| CCR2 | chemokine (C-C motif) receptor 2 | 1.000 | Human | |
| CCR5 | chemokine (C-C motif) receptor 5 | 0.998 | Human | |
| IL2RB | interleukin 2 receptor, beta | 0.992 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.967 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.935 | ||
| IRF4 | interferon regulatory factor 4 | 0.926 | ||
| IFNG | interferon, gamma | 0.914 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.911 | Human | |
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.862 | ||
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.832 | Human | |
| CCR7 | chemokine (C-C motif) receptor 7 | 0.831 | Human | |
| CD40LG | CD40 ligand | 0.733 | ||
| IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.617 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.608 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.554 | Human | |
| SLAMF7 | SLAM family member 7 | 0.552 | ||
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.525 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.505 | Human | |
| IL10 | interleukin 10 | 0.435 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.397 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.342 | ||
| CD86 | CD86 molecule | 0.310 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.293 | ||
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.278 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.273 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.218 | ||
| CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.215 | Human | |
| CLEC7A | C-type lectin domain family 7, member A | 0.187 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.182 | ||
| CCR6 | chemokine (C-C motif) receptor 6 | 0.157 | Human | |
| IL1R2 | interleukin 1 receptor, type II | 0.150 | ||
| LAG3 | lymphocyte-activation gene 3 | 0.146 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.139 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.129 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.121 | ||
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.103 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.098 | ||
| GZMK | granzyme K (granzyme 3; tryptase II) | 0.098 | ||
| CLEC4A | C-type lectin domain family 4, member A | 0.095 | ||
| IL21R | interleukin 21 receptor | 0.093 | ||
| CD2 | CD2 molecule | 0.087 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.086 | ||
| TNF | tumor necrosis factor | 0.085 | ||
| CD1C | CD1c molecule | 0.085 | ||
| SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 0.085 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.084 | ||
| PRAF2 | PRA1 domain family, member 2 | 0.082 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.082 | ||
| LGALS2 | lectin, galactoside-binding, soluble, 2 | 0.078 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.075 | ||
| CD80 | CD80 molecule | 0.074 | ||
| CYBB | cytochrome b-245, beta polypeptide | 0.074 | ||
| P2RY10 | purinergic receptor P2Y, G-protein coupled, 10 | 0.073 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.072 | Human | |
| CD22 | CD22 molecule | 0.066 | ||
| LTB | lymphotoxin beta (TNF superfamily, member 3) | 0.065 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.057 | ||
| FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.055 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.054 | ||
| TLR2 | toll-like receptor 2 | 0.051 | ||
| CXCR2 | chemokine (C-X-C motif) receptor 2 | 0.051 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.050 | ||
| GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.048 | ||
| CLEC4E | C-type lectin domain family 4, member E | 0.047 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.046 | ||
| CD79A | CD79a molecule, immunoglobulin-associated alpha | 0.044 | ||
| FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 0.043 | ||
| FGL2 | fibrinogen-like 2 | 0.041 | ||
| CD28 | CD28 molecule | 0.040 | ||
| IGSF6 | immunoglobulin superfamily, member 6 | 0.040 | ||
| FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0.039 | ||
| RNASE2 | ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) | 0.039 | ||
| EVI2B | ecotropic viral integration site 2B | 0.037 | ||
| CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.037 | ||
| CD48 | CD48 molecule | 0.036 | ||
| GNAO1 | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O | 0.035 | ||
| CCR8 | chemokine (C-C motif) receptor 8 | 0.034 | Human | |
| AQP9 | aquaporin 9 | 0.034 | ||
| IL4 | interleukin 4 | 0.033 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.033 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.033 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.032 | ||
| ITK | IL2-inducible T-cell kinase | 0.032 | ||
| CD93 | CD93 molecule | 0.032 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.032 | ||
| CLEC5A | C-type lectin domain family 5, member A | 0.031 | ||
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.031 | ||
| SPOCK2 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 | 0.031 | ||
| CD19 | CD19 molecule | 0.030 | ||
| GPR18 | G protein-coupled receptor 18 | 0.030 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.030 | ||
| BIN2 | bridging integrator 2 | 0.029 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.028 | ||
| ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) | 0.028 | ||
| IL1B | interleukin 1, beta | 0.027 | ||
| SASH3 | SAM and SH3 domain containing 3 | 0.027 | ||
| LAX1 | lymphocyte transmembrane adaptor 1 | 0.027 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.026 | ||
| MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.026 | ||
| SIT1 | signaling threshold regulating transmembrane adaptor 1 | 0.026 | ||
| SELL | selectin L | 0.026 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.026 | ||
| CCR9 | chemokine (C-C motif) receptor 9 | 0.026 | Human | |
| KLRK1 | killer cell lectin-like receptor subfamily K, member 1 | 0.026 | ||
| IL1A | interleukin 1, alpha | 0.025 | ||
| MSR1 | macrophage scavenger receptor 1 | 0.025 | ||
| IL6R | interleukin 6 receptor | 0.025 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.025 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.025 | ||
| GIMAP4 | GTPase, IMAP family member 4 | 0.024 | ||
| TBX21 | T-box 21 | 0.023 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.023 | ||
| UBASH3A | ubiquitin associated and SH3 domain containing A | 0.022 | ||
| AOAH | acyloxyacyl hydrolase (neutrophil) | 0.022 | ||
| XCR1 | chemokine (C motif) receptor 1 | 0.022 | Human | |
| CD3G | CD3g molecule, gamma (CD3-TCR complex) | 0.021 | ||
| CD6 | CD6 molecule | 0.021 | ||
| TLR7 | toll-like receptor 7 | 0.020 | ||
| KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.020 | ||
| CLC | Charcot-Leyden crystal protein | 0.019 | ||
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.019 | ||
| RNASE6 | ribonuclease, RNase A family, k6 | 0.019 | ||
| CD160 | CD160 molecule | 0.019 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.018 | ||
| C3AR1 | complement component 3a receptor 1 | 0.018 | ||
| RUNX3 | runt-related transcription factor 3 | 0.017 | ||
| CLEC10A | C-type lectin domain family 10, member A | 0.017 | ||
| FPR2 | formyl peptide receptor 2 | 0.017 | ||
| NCR3 | natural cytotoxicity triggering receptor 3 | 0.017 | ||
| PDCD1LG2 | programmed cell death 1 ligand 2 | 0.016 | ||
| KLRG1 | killer cell lectin-like receptor subfamily G, member 1 | 0.016 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.016 | ||
| CD1A | CD1a molecule | 0.016 | ||
| CD163 | CD163 molecule | 0.016 | ||
| IL17A | interleukin 17A | 0.016 | ||
| BATF | basic leucine zipper transcription factor, ATF-like | 0.015 | ||
| CD4 | CD4 molecule | 0.015 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.015 | ||
| IL18R1 | interleukin 18 receptor 1 | 0.015 | ||
| TDRD12 | tudor domain containing 12 | 0.015 | ||
| FAIM3 | Fas apoptotic inhibitory molecule 3 | 0.015 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.015 | ||
| PTAFR | platelet-activating factor receptor | 0.015 | ||
| IL5 | interleukin 5 (colony-stimulating factor, eosinophil) | 0.014 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.014 | ||
| ITGB7 | integrin, beta 7 | 0.014 | ||
| GPR109B | G protein-coupled receptor 109B | 0.014 | ||
| FFAR2 | free fatty acid receptor 2 | 0.014 | ||
| XCL2 | chemokine (C motif) ligand 2 | 0.014 | ||
| SIRPB1 | signal-regulatory protein beta 1 | 0.014 | ||
| SLAMF6 | SLAM family member 6 | 0.014 | ||
| MMP8 | matrix metallopeptidase 8 (neutrophil collagenase) | 0.013 | ||
| KCNA3 | potassium voltage-gated channel, shaker-related subfamily, member 3 | 0.013 | ||
| GPR171 | G protein-coupled receptor 171 | 0.013 | ||
| KCNJ15 | potassium inwardly-rectifying channel, subfamily J, member 15 | 0.013 | ||
| NPL | N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) | 0.013 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.013 | ||
| CCL23 | chemokine (C-C motif) ligand 23 | 0.013 | ||
| CD83 | CD83 molecule | 0.013 | ||
| GPA33 | glycoprotein A33 (transmembrane) | 0.013 | ||
| CLEC1A | C-type lectin domain family 1, member A | 0.013 | ||
| S100A12 | S100 calcium binding protein A12 | 0.012 | ||
| CD1E | CD1e molecule | 0.012 | ||
| IL12RB1 | interleukin 12 receptor, beta 1 | 0.012 | ||
| CASP5 | caspase 5, apoptosis-related cysteine peptidase | 0.012 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.012 | ||
| ADORA3 | adenosine A3 receptor | 0.012 | ||
| ST8SIA4 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 | 0.012 | ||
| C2 | complement component 2 | 0.012 | ||
| FPR1 | formyl peptide receptor 1 | 0.011 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.011 | ||
| GRAP2 | GRB2-related adaptor protein 2 | 0.011 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.011 | ||
| FPR3 | formyl peptide receptor 3 | 0.011 | ||
| PRDM1 | PR domain containing 1, with ZNF domain | 0.011 | ||
| ZBED2 | zinc finger, BED-type containing 2 | 0.011 | ||
| IRF8 | interferon regulatory factor 8 | 0.011 | ||
| LY9 | lymphocyte antigen 9 | 0.011 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.011 | ||
| CNR2 | cannabinoid receptor 2 (macrophage) | 0.011 | ||
| AIM2 | absent in melanoma 2 | 0.011 | ||
| HLA-DQB2 | major histocompatibility complex, class II, DQ beta 2 | 0.011 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.011 | ||
| ZBP1 | Z-DNA binding protein 1 | 0.011 | ||
| HAL | histidine ammonia-lyase | 0.010 | ||
| CSF1R | colony stimulating factor 1 receptor | 0.010 | ||
| LY86 | lymphocyte antigen 86 | 0.010 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.010 | ||
| VPREB3 | pre-B lymphocyte 3 | 0.010 | ||
| GNAT2 | guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2 | 0.010 | ||
| MARCO | macrophage receptor with collagenous structure | 0.010 | ||
| RNASE3 | ribonuclease, RNase A family, 3 | 0.010 | ||
| TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 | 0.010 | ||
| CPVL | carboxypeptidase, vitellogenic-like | 0.010 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.010 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.010 |